43 /100
MEDIUM RISK
Score updated Apr 13, 2026

GANX

Gain Therapeutics, Inc. — Stock Dilution Tracker

Track GANX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track GANX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GANX.
🔔 Track GANX — Get forecast alerts →
💹 Market Data
Market Cap$76.48M
Shares Outstanding42.49M
Float40.90M
Cash$20.84M
Debt$732.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 86.9% shares (2025Q4 vs prior)
49 institutional holders · 8.18M shares
#1 MARSHALL WACE, LLP 1.66M shares
#2 Potomac Capital Management, Inc. 1.01M shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 728.9K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.28M
Days to Cover4.0
% of Float8.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track GANX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GANX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required